Giulia Pasello

机构：University of Padua, Radiation Oncology Institute, Istituto Oncologico Veneto, Istituti di Ricovero e Cura a Carattere Scientifico · ORCID：0000-0002-8741-6038

发表论文 331 篇 · 总被引 5093 次 · h-index 33

代表论文

• Dissecting the prognostic role of metabolic markers in lung neuroendocrine Tumors: The MONET study (2026 · Lung Cancer · 被引 1)
• HYPERPROGRESSION UPON CEMIPLIMAB ALONE OR WITH SHORT COURSE CHEMOTHERAPY IN PD-L1≥50% NON-SMALL CELL LUNG CANCER: A BIOMARKER GUIDED MULTICENTER INTERNATIONAL PHASE 2 TRIAL – HYPERBOLIC STUDY (2026 · Clinical Lung Cancer)
• Comparing Real-Time PCR and Amplicon-Based NGS for Routine EGFR Liquid Biopsy Profiling (2026 · Diagnostics)
• Brief report: attitudes and barriers toward genetic testing in pleural mesothelioma: a nationwide Italian survey (2026 · Familial Cancer)
• EGFR-mutant NSCLC progressing on first-line osimertinib: rebiopsy in real-world and impact of second-line therapies (the ‘Rebiopsy on osi’ Study) (2026 · The Oncologist)
• Anti-TROP2 Antibody Drug Conjugates in EGFR-Mutant Non-Small Cell Lung Cancer: Biological Rationale and Clinical Challenges (2026 · Pharmaceutics)